Article
Clinical and molecular models of Glioblastoma multiforme survival
1 Jan 2013
Abstract excerpt
Glioblastoma multiforme (GBM), a highly aggressive form of brain cancer, results in a median survival of 12-15 months. For decades, researchers have explored the effects of clinical and molecular factors on this disease and have identified several candidate prognostic markers. In this study, we evaluated the use of multivariate classification models for differentiating between subsets of patients who survive a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
